ASSESSMENT OF LIPID PROFILE CHANGES IN PRE-MENOPAUSAL AND POST-MENOPAUSAL WOMEN AND THEIR ASSOCIATION WITH CARDIOVASCULAR RISK
DOI:
https://doi.org/10.5281/zenodo.21240464Keywords:
Atherosclerosis, Cardiovascular Disease, Estrogen, Lipid Profile, Pre-menopausal, Post-menopausalAbstract
Objectives: Menopause is the permanent cessation of menstruation; since cardiovascular disease is the leading cause of death among post-menopausal women, which may be due to lower level of estrogen. The present study was undertaken to evaluate serum estrogen and lipid profile status in post-menopausal women and compare with premenopausal women.
Materials and Methods: 50 post-menopausal women and 50 pre-menopausal women in the reproductive age group were selected in the study. We measured serum estrogen and serum lipid profile [total cholesterol (TC), triglyceride (TG), HDL Cholesterol, LDL-Cholesterol, and VLDL-Cholesterol.] in both pre and post-menopausal women. The comparison and correlation of estrogen level with lipid profile was done using correlation test and P value less than 0.05 was considered significant. Serum estrogen and lipid profile determinations were done by competitive binding immunoassay and enzymatic methods respectively.
Results: This study showed statistically significant lower values of serum estrogen in post-menopausal women compared to premenopausal women. (p<0.001). Significant higher values of serum TC, TG, LDL-C and VLDL-C levels and significant lower values of HDL-C in post-menopausal women compared to pre-menopausal women (p<0.001).
Conclusion: Our study showed altered serum lipid profile in post-menopausal women, hence they are at an increased risk for cardiovascular diseases. Estrogen may be the protective factor in premenopausal women. Therefore screening for lipid profile and specific health education is needed for all postmenopausal women to prevent the emerging cardiovascular diseases.
References
I. Anita Deshpande, Sumangala Patil et al. A Study of Atherosclerotic Risk Factors in Postmenopausal Women. International Journal of Biomedical and Advance Research (IJBAR) 2012;03(08):645-647.
II. Srinivas Reddy Kilim, Srinivasa Rao Chandala. A Comparative Study of Lipid Profile and Oestradiol in Pre- and Post-Menopausal Women. Journal of Clinical and Diagnostic Research. 2013 Aug; Vol-7(8):1596-1598.
III. Judith Wylie-Rosett. Menopause, micronutrients, and hormone therapy. Am J Clin Nutr 2005;81:1223–31.
IV. World Health Report. Reducing risks, promoting Healthy life, Geneva World Health Organization, 2002.
V. Zipes, Libby, Bonow, Braunwald; Braunwalds Heart Disease. A textbook of cardiovascular Medicine, 7th ed, Philadelphia, Pennsylvania; Elsevier Saunders Publishers, 2005.
VI. Maulik, S. Varu, et al. A Comparative Study of Serum Lipid Profile between Premenopausal and Postmenopausal Women. National Journal of Integrated Research in Medicine (NJIRM) 2011;2(4):43-45.
VII. Grady D, Rubin SM, Petitti DB et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992 Dec 15;117(12):1016-37.
VIII. Arora S, Jain A, Chitra R. Effects of short-term hormone replacement on a atherogenic indices in Indian postmenopausal women. Indian Journal of Clinical Biochemistry (IJCB) 2006;21(1):41-7.
IX. Jan Nilsson. CRP—Marker or Maker of Cardiovascular Disease? Arterioscler Thromb Vasc Biol. published by the American Heart Association 2005;25:1527-1528.
X. Nader Rifai, G Russell Warnick. Lipids, Lipoproteins, Apolipoproteins and Other Cardiovascular Risk Factors. In: Carl A Burtis, Edward R Ashwood, David E Burn, eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 4th ed. Saunders, 2006:903-98.
XI. Koenig W. C-reactive protein; risk assessment in the primary prevention of atherosclerotic disease. Has the time come for including it in the risk profile? Ital Heart J. 2001 Mar;2(3):157-63.
XII. De Beer FC, Hind CR, Fox KM, Allan RM, Maseri A, Pepys MB. Measurement of serum C-reactive protein in myocardial ischaemia and infarction. Br Heart J 1882;47:239-43.
XIII. Biomerieux SA RCS LYON 673 620 399, 69280 Marcy-I toile/france, www.biomerieux.com,VIDAS Estradiol II; 08098L-en-2010/06.REF 30431.
XIV. Pamelo C Champe, Richard A Harvey, Denise R Ferrier.
XV. Obesity. In: Lippincott’s Illustrated Review Biochemistry. 3rd ed. Lippincott Williams and Wilkins, 2005:347-349.
XVI. K Park. Non Communicable Diseases and Conditions, Obesity. In: Park’s Textbook of Preventive and Social Medicine. 21th ed. M/S Banarsidas Bhanot, 2011:369370.
XVII. Gordon T, Kannel WB, Huortland MC, McNamara PM. Menopause and coronary heart disease. The Framingham study. Ann Intern Med 1978 Aug;89(2):157-61.
XVIII. Shilpa S. Shende, M.V. Bimanpalli, I.C. Apte, Vishakha Vet al. Study of Lipid Profile and C Reactive Protein in Pre- and Post-menopausal Women. Journal of Clinical and Diagnostic Research. 2011 Dec;5(8):1544-1547.
XIX. Hallberg L, Svanborg A. Cholesterol, phospholipids and triglycerides in plasma in 50 year-old women. Acta Med Scand 1967;181(2):185-94.
XX. Tanko LB, Alexandersen P, Larsen PJ et al. Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women. Circulation 2005 April 19;111:1883-90.
XXI. Swarnalatha PK, Ebrahim NKC. A Correlative Study of Estrogen and Lipid Profile in Premenopausal and Postmenopausal Women. International Journal of Biomedical and Advance Research (IJBAR) 2012;03(11):818-821.
XXII. Razay G, Heaton KW, Bolton CH. Coronary heart disease risk factors in relation to the menopause. Quarterly J of Med 1992 Nov-Dec;85(307-8):889-96.
XXIII. Shilpa S Shende, C M Iyer et al. Effect of duration on lipid profile status in post-menopausal women. The Health Agenda July 2014;2(3):90-94.
XXIV. Muzzio ML, Berg G, Zago V, Lopez G, et al. Circulating small dense LDL, endothelial injuring factors and fibronectin in healthy postmenopausal women. Clin Chim Acta 2007;381:157-163.
XXV. Sushil Kumar et al. Study of Cardiovascular Risk Factors in Pre and Postmenopausal Women. International Journal of Pharma Sciences and Research (IJPSR). 2012 Dec;3(12):560-570.
XXVI. Wakatsuki A, Sagara Y. Lipoprotein metabolism in postmenopausal and oophorectomized women. Obstet Gynecol 1995 April;85(4):523-8.
XXVII. Kannel WB. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham study. Am Heart J 1987 Aug;114(2):413-9.
XXVIII. Sultan N, Nawaz M, Sultan A, Fayaz M, Baseer A. Effect of menopause on serum HDL-cholesterol level. J Ayub Med Coll Abbottabad (JAMC) 2003 Jul-Sep;15(13).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 International Educational Applied Scientific Research Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
